A memorandum of understanding with Switzerland's CSEM was signed electronically on 2 July 2026 and is valid for two years. The parties jointly develop vital-sign monitoring — heart rate, HRV, SpO₂, blood pressure and EEG — integrated into smart glasses. GeniusMed leads the project and system integration; CSEM contributes optical sensing, biopotentials and digital-health R&D.
A joint proposal for the 11th Eurostars call is being prepared with CSEM (deadline 10 September 2026). If selected, the Korean SME is funded for up to 67% of project cost through the Korea Institute for Advancement of Technology, strengthening eligibility for global government R&D funding.